Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 8/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.36 |
| ▸ | PRKDC | P78527 | 2/20 | 0.36 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.36 |
| ▸ | F9 | P00740 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22135452 | 0.98 | ALOX5 (0.42) | ALOX5MAPTALDH1A1KDM4EPOLB | |
| SCHEMBL22135394 | 0.97 | ALOX5 (0.41) | ALOX5MAPTALDH1A1KDM4EPOLB | |
| SCHEMBL25645976 | 0.97 | ALOX5 (0.41) | ALOX5MAPTALDH1A1KDM4EPOLB | |
| SCHEMBL25950676 | 0.97 | ALOX5 (0.41) | ALOX5MAPTALDH1A1KDM4EPOLB | |
| SCHEMBL25050140 | 0.97 | ALOX5 (0.43) | ALOX5MAPTALDH1A1KDM4EPOLB | |
| SCHEMBL25851981 | 0.97 | ALOX5 (0.45) | ALOX5MAPTALDH1A1KDM4EPOLB | |
| SCHEMBL23349883 | 0.96 | ALOX5 (0.46) | ALOX5MAPTALDH1A1KDM4EPOLB | |
| SCHEMBL23349571 | 0.96 | ALOX5 (0.40) | ALOX5MAPTALDH1A1KDM4EPOLB | |
| SCHEMBL22330215 | 0.96 | ALOX5 (0.42) | ALOX5MAPTALDH1A1KDM4EPOLB | |
| SCHEMBL22329712 | 0.96 | ALOX5 (0.42) | ALOX5MAPTALDH1A1KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024143905-A1 | ORGANIC ELECTRIC ELEMENT USING ORGANIC ELECTRIC ELEMENT COMPOUND, AND ELECTRONIC DEVICE | 덕산네오룩스 주식회사 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024143995-A1 | ORGANIC ELECTRIC ELEMENT USING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024143996-A1 | ORGANIC ELECTRIC ELEMENT USING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024111891-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME | 덕산네오룩스 주식회사 | 2024-05-30 | — | — | WO | disclosed |
| US-20230247899-A1 | ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-20230247899-A1 | ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-20230172055-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172055-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-11665958-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-05-30 | — | — | US | disclosed |
| US-11665958-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-05-30 | — | — | US | disclosed |
| WO-2022139445-A1 | ORGANIC ELECTRIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022010302-A1 | ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2022-01-13 | — | — | WO | disclosed |
| WO-2020032428-A1 | ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT AND ELECTRONIC DEVICE USING SAME | 덕산네오룩스 주식회사 | 2020-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230247899-A1 | ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR | SLC39A11, LEF1, SLC39A14 | ALOX5 1605/4885MAPT 1602/4885ALDH1A1 670/4885 |
| US-20230172055-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | OR51E2, NFE2L2, ETV6 | ALOX5 509/4885MAPT 999/4885ALDH1A1 1609/4885 |
| US-11665958-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | OR51E2, NFE2L2, ETV6 | ALOX5 509/4885MAPT 999/4885ALDH1A1 1609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.